SMM Global – Stock Market Manager Stock Market Manager simplifies distribution and disclosure of press releases, research and corporate news to financial terminals, print, broadcast and trade media, wire services, news agencies, databases, portals and websites.
Weekly Update: April 1, 2021
Black Swan Connection Newsletter Signup
Breaking News-
Seems that Optimism abounds in our almost post Covid world. I guess nobody cares about the big corporate tax hikes coming or the trillions in new debt. They will at some point………
Stock market news live updates: S&P 500 tops 4,000 for the first time, Nasdaq gains more than 1%
Yahoo Finance 4-1-21
Stocks traded higher Thursday, extending gains in another record-setting day on Wall Street.
The S&P 500 gained about 0.7% shortly after the opening bell, breaking above 4,000 for the first time ever. The Nasdaq outperformed to rise more than 1% as technology stocks jumped. Shares of electric-vehicle stocks including Workhorse Group (WKHS) and Plug Power (PLUG) increased after President Joe Biden discussed the details of his more than $2 trillion infrastructure plan, which would include building out half a million EV charging stations.
Read Complete Article
Introducing the new:
China Stock Alerts Newsletter
China Stock Alerts provides timely information on China and the Chinese companies listed in the US on our website and daily newsletter. Please SUBSCRIBE for our daily newsletter, which is sent out before the market opens and features previous day gainers and losers, market and company specific news, and an updated calendar of earnings.
China Stock Alerts
TOP NEWS
April 1, 2021
- China’s central bank warns of a swath of financial risks, including potential defaults (CNBC)
- China Approves Merger of Chemical Giants, Creating $150 Billion Company (WSJ)
- G7 pressure on China over subsidies ‘doomed to fail’ even as Biden administration gathers coalition (SCMP)
- US-China relations: trade chief Katherine Tai lays out hardline approach with ‘world’s leading offender’ label (SCMP)
- China’s expat tax reform could see more than a third of American firms leave Shanghai, AmCham says (SCMP)
Read Complete Report for April 1, 2021
3-31-21 Greenridge Global Securities Issues Update
Guangdong Land Holdings, Ltd. [HKSE: 0124]
Maintaining Buy Rating and Target HK$5.00
Dividend Announced As Portfolio Development Continues On Schedule
Strong Laurel House Sales Drive Down Margins And Profit. GDL reported Revenue of RMB 2,101.8 million in H2:20, inline with our estimate. The bulk of the Revenue in the period was from Laurel House, which delivered 22,425m2 in the second half, bringing its amount delivered to 82.6%. There is another 8,545m2 contracted and awaiting delivery, which brings the total contracted GFA to 95.6%; GD●Delin ended with an occupancy rate of 85.4%. NW Land of GDH City delivered 4,577m2 in H2:20 after making initial deliveries in June. However, GDL added 20,279m2 in contracted sales during the period, bringing the total contracted GFA to 38,902m2 and foreshadows stronger 2021 Revenue. The remainder of the Revenue in the period was from delivery of car parking spaces at Ruyingju. Operating expenses surged in the period, with SG&A more than doubling from the year ago period to HK$262.0 million. The increase was related to the expansion of sales activities, specifically with GDH City, and the greater number of properties in GDL’s portfolio. Net Loss for the Period was HK$54.9 million, worse than expected due to higher SG&A and lower Gross Margins due to the Revenue mix skewing heavy towards Laurel House.
Dividend Announced. GDL announced a dividend of HK1.53 cents per share for the year ending 2020, which comes as a bit of a surprise given it is using a significant amount of cash for its ongoing portfolio development. We believe the dividend shows management’s confidence in the development of the portfolio in a profitable and on-budget manner. The date of record for payment is expected to be on or around June 25, 2021.
Model Update. The biggest changes to our model was adjusting H1:21 related to GDH City and Laurel House, as well as increasing the SG&A going forward. The net results had a minimal impact on the overall model.
Maintaining Rating & Target. The Company reported another period of strong unit sales and deliveries, with the entire portfolio continuing to move on schedule. With no meaningful changes over the model we are reiterating our Buy rating and HK$5.00 target price on Guangdong Land Holdings. Our target price is based on our DCF model that covers GDL’s entire project portfolio, discounted at 6.5%.
Read Complete Report
2-29-2021 Antibe Therapeutics Inc. OTC ATBF (TSXV:ATE)
Antibe Therapeutics Receives FDA Clearance of IND Application for Otenaproxesul for Osteoarthritis Pain
– Enables expansion to U.S.-based clinical trials, advances preparation for Phase III program
Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies for inflammation arising from a wide range of medical conditions, today announced that the U.S. Food and Drug Administration (“FDA”) has cleared the Company’s Investigational New Drug (“IND”) application for otenaproxesul, in development for the treatment of osteoarthritis pain. This enables Antibe to undertake human clinical trials in the U.S.; as previously announced, Antibe anticipates initiating its Phase III program later this year.
Read Complete Report
3-17-2021 Blue Water Ventures International, Inc. (OTCPK:BWVI) and project partner Endurance Exploration Group, Inc. (OTC:EXPL)
Blue Water Ventures International Signs Extension on Pulaski Recovery
Jacksonville, FL, March 17, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Blue Water Ventures International, Inc. (OTCPK:BWVI) and project partner Endurance Exploration Group, Inc (OTC:EXPL) through its wholly own subsidiary Swordfish Partners have confirmed that both parties have agreed to an extension of the Pulaski Joint Venture through year end 2022.
The extension will allow the joint venture additional time to complete the recovery on the existing work site of the Pulaski and expand its survey to an additional area of interest, believed to be the resting place of the 2nd half of the Pulaski when she exploded during the night in June 1838. The current area of work includes the boiler and main common areas of the ship. The 2nd area of interest should include passenger staterooms and baggage compartments. Past year’s exploration of the Pulaski site has produced over 500 coins, pocket watches, silver ware sets and copious amounts of shipwreck material.
Read Complete Report
3-15-21 SRAX, Inc. (NASDAQ: SRAX), SRAX Releases the shelf Registration Feature on the Sequire Platform
SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, has announced the release of its Shelf Registration Feature. This new Sequire addition combines data and technology to provide actionable insights to public companies in regards to their shelf availability.
The new shelf registration feature joins many other unique and robust Sequire features such as warrant management, situation room, and shareholder surveys.
The shelf feature enables shelf eligible users to review and keep track of their shelf registration and current shelf availability. Included with this is the Shelf Prediction Tool: a real-time application to explore potential “market windows,” showing the impact of market volatility and thus improving funding plans.
Read Complete Report
3-18-21 Can B Corp. (OTCQB: CANB)
Can B Corp. Acquires Assets from Leading-Edge Hemp Technology Group
Adds Expertise in Pharmacokinetics for the Confluence of Science, Nature, and Culture
HICKSVILLE, NY / ACCESSWIRE / March 18, 2021 / Can B Corp. (OTCQB:CANB) (“Can B” or the “Company”), a diversified health and wellness company, is pleased to announce it has closed on the acquisition of assets and talent from a hemp derivative development and manufacturing group. A newly formed wholly-owned subsidiary, Botanical Biotech LLC (“BB”), will be the new home for Florida-based research & development laboratory and extraction facility for the Company. BB will focus on developing and implementing new pharmacokinetics technology and partnering with global and emerging brands to create innovative products and solutions that are positioned for sustainability and wellness and are culturally driven.
Read Complete Report
3-15-21 Greenridge Global Securities Issues Update
Guangdong Land Holdings, Ltd. [HKSE: 0124]
Maintaining Buy Rating and Target HK$5.00
GDH City Site Visit & Update
GDH City Site Visit & Updates. We were recently able to arrange a site visit of GDH City to get an update on the project, which continues to move on schedule (see pictures on pages 2 and 3). Additionally, we were told the customer interest in the apartments on the Northwest Land continues to remain strong. GDL has also made a number of announcements regarding the selection of contractors for different GDH City projects recently. Earlier this month, it announced contractor agreements for the Northern Land, which is still scheduled to be completed in the second half of 2022. It retained China Construction Dongfang to complete the Office Tower Fitting-Out Work at the Northern Land by January 31, 2022 at a cost of just under RMB 80,000,000. It also disclosed it retained China Construction Shenzhen to complete the Commercial Shopping Fitting-Out Work on the Northern Land by June 30, 2021 at a cost of nearly RMB 62,000,000. Last month, it announced the selection of China Railway Tunnel Group [HK: 390] to complete the tunnel pedestrian link to the subway at the Southern Land, which is scheduled to be completed by July 6, 2021 at a total cost of roughly RMB 79,000,000.
RMB400,000,000 Factoring Agreement. Last week, GDL announced it entered into a RMB400,000,000 factoring agreement with Foshan Yuehai. The factoring service charge will be 6.5%, making it a relatively inexpensive source of cash for continued project development. The agreement will run through the end of 2021.
Year-End Results. GDL will hold a Board meeting on Friday, March 26 to approve the 2020 annual results. We expect the results to be released shortly thereafter.
Model Update. We made no changes to our model.
Maintaining Rating & Target. The site visit was positive and the announced contract terms have largely fallen inline with our estimates. With no changes to our model we are reiterating our Buy rating and HK$5.00 target price on Guangdong Land Holdings. Our target price is based on our DCF model that covers GDL’s entire project portfolio, discounted at 6.5%.
Read Complete Report
3-3- 2021 Antibe Therapeutics Inc. OTC ATBF (TSXV:ATE)
Antibe Therapeutics to Present at Upcoming Virtual Investor Conferences
Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its unique hydrogen sulfide platform to develop next-generation safer therapies to address inflammation arising from a wide range of medical conditions, today announced its participation in the following investor conferences in March:
H.C. Wainwright Global Life Sciences Conference on Tuesday, March 9, 2021 at 7:00 am (Eastern Time) a pre-recorded company presentation will become available for on-demand viewing.
Roth Capital Partners Annual Conference, Live fireside chat on Monday, March 15, 2021, at 9:00 am (Eastern Time).
Oppenheimer & Co. 31st Annual Healthcare Conference, Company presentation on Tuesday, March 16, 2021 at 9:20 am (Eastern Time).
Maxim Group Emerging Growth Virtual Conference on Wednesday, March 17, 2021 at 10:00 am (Eastern Time) a pre-recorded company presentation will become available for on-demand viewing.
Read Complete Report
2-25-21 Perpetual Industries, Inc. (OTC: PRPI)
Video Update with Perpetual and Worldwide Auctioneers following the recent acquisition of Worldwide Auctioneers by Perpetual Industries, Inc.
Check out the latest video with CEO Brent Bedford in this casual fire-side chat with managing partners John Kruse and Rod Egan of Worldwide Auctioneers. They discuss the recent acquisition and share a glimpse into what the future might look like for Perpetual’s new wholly-owned subsidiary.
Watch Complete Video
2-23-21 Can B Corp. (OTCQB: CANB)
Can B Corp. Executes Definitive Agreement to Acquire the Assets of Imbibe Health Solutions
Business Entrepreneur and Advertising and Marketing Expert Walter Hoelzel to Join Can B
HICKSVILLE, NY / ACCESSWIRE / February 23, 2021 / Can B Corp. (OTCQB:CANB) (“Can B” or the “Company”), a diversified health and wellness company, is pleased to announce it has signed a definitive agreement to acquire the assets of Imbibe Health Solutions LLC (“Imbibe”), a developer and marketer of CBD and related products.
Imbibe has developed several CBD health and wellness products including topical salves, bath soaks, massage oils, and energy and dietary supplements. CANB will be putting Imbibe into one of its current inactive wholly-owned subsidiaries and will be renaming that subsidiary to reflect the products and culture that comes with the Imbibe acquisition.
Read Complete Report
2-17-2021 Antibe Therapeutics Inc. OTC ATBF (TSXV:ATE)
Antibe Therapeutics Announces C$35 Million Bought Deal Public Offering
TORONTO, Feb. 17, 2021 /CNW/ – Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSX: ATE) today announced that it has entered into an agreement with Canaccord Genuity Corp. on behalf of a syndicate of underwriters (together, the “Underwriters”) and pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 5,850,000 units (the “Offered Securities”) in the capital of the Company at a price of C$6.00 per Offered Security (the “Offering Price”) for aggregate gross proceeds to the Company of C$35,100,000 (the “Offering”).
Read Complete Report
1-11-2021 Antibe Therapeutics Inc. OTC ATBF (TSXV:ATE)
Antibe Therapeutics Announces Strategic Licensing Deal in China With Nuance Pharma
– US$100 million in milestone payments including US$20 million upfront, as well as a double-digit royalty
– Nuance’s business model, commercial acumen and collaborative approach considered an ideal fit for Antibe
Antibe Therapeutics Inc. (TSX: ATE, OTCQB: ATBPF) today announced that it has licensed otenaproxesul to Nuance Pharma for commercialization in the Greater China region. Nuance is a biopharmaceutical company focused on licensing, developing and commercializing globally innovative therapies to address critical unmet medical needs in China and other Asia Pacific markets. Founded by Mark Lotter, who built the AstraZeneca commercial franchise in China, and led by executives with extensive multinational pharma experience, Nuance focuses on identifying and in-licensing therapies that have achieved best-in-class, human proof-of-concept status.
Read Complete Report
2-8-21 Greenridge Global Securities Issues Update
Guangdong Land Holdings, Ltd. [HKSE: 0124]
Maintaining Buy Rating and Target HK$5.00
HK$1.0 Billion Loan Facility Announced
HK$1.0 Billion Loan Facility. Last week, GDL announced it entered into a term facility with an undisclosed bank for HK$1.0 billion. The announcement of such a facility has been expected as the Company continues to add to its property portfolio. We expect the funds will be used for development and operating expenses in between cash receipts from the pre-sale and sale of completed properties.
Acquisitions Completed. On January 13, the Jiangmen Acquisition was completed and on January 18, the Huizhou Acquisition was completed. Please see our November 2, 2020 and December 16, 2020 reports for additional details.
Model Update. We made no changes to our model as we had assumed bank financing and the completion of both acquisitions.
Maintaining Rating & Target. The news since our last update had largely been expected. With no changes to our model we are reiterating our Buy rating and HK$5.00 target price on Guangdong Land Holdings. Our target price is based on our DCF model that covers GDL’s entire project portfolio, discounted at 6.5%.
Read Complete Report
1-13-2021 SRAX, Inc. Nasdaq SRAX
SRAX to Host and Present at the B. Riley Securities 2021 Vision Day on the Sequire Virtual Events Platform
SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, announced that it will be hosting the B. Riley Securities 2021 Vision Day via its Sequire Virtual Events platform, and presenting at the event as one of B. Riley’s top picks for 2021.
Sequire’s Virtual Events platform, allowing companies to virtually present to institutional and retail investors, is the most recent addition to the suite of products on the Sequire platform. “We recognize that virtual events are here to stay, and for public companies, the platform offers everything issuers need to host their meetings with maximum exposure,” said Christopher Miglino, Founder and CEO of SRAX.
Read Complete Report
1-11-2021 Antibe Therapeutics Inc. OTC ATBF (TSXV:ATE)
Antibe Therapeutics Provides 2021 Corporate Update
– Large market partnering program now underway –
– Limited COVID-19 impact: Phase III program slated to start in second half of 2021 –
– U.S. institutional outreach expanding –
Antibe Therapeutics Inc.:
To our shareholders,
As we build on last year’s significant clinical and capital markets achievements and enter the homestretch in the strategic monetization of otenaproxesul, we want to update you on our progress and plans. We are particularly gratified by the recent uptick in interest by both global and regional potential partners, supporting otenaproxesul’s compelling value proposition and revenue opportunity. We are also encouraged by the response to our U.S. institutional outreach, further validating our strategy for unlocking the value of our assets as we move toward a potential listing on a senior U.S. exchange.
Read Complete Release
1-6-21 Greenridge Global Securities Issues Update
Apollo Future Mobility Group, Ltd.[HKSE: 0860]
Buy Rating-Target HK$ 1.50
Ideenion Acquisition EGM set
Ideenion Acquisition Update. AMFG released the Circular for the Ideenion acquisition and announced it is holding an Extraordinary General Meeting on January 29 at 11am in Science Park to vote on the acquisition. A few key notes from the Circular include that prior to COVID, Ideenion was generating roughly HK$157.6 million in Revenue and HK$37.9 million in Net Profit per year. Despite being impacted by COVID, it has a pipeline of projects worth roughly €24,450,000 (HK$233,000,000), as well as being in final negotiations with an emerging market client for a fuel cell vehicle and an EV setup with a total project value of €49,000,000 (HK$467,000,000), which gives the vendors confidence in the profit targets being reached for the contingent cash and share issuances. The independent valuer found a current valuation of €22,000,000. AMFG is paying €15,000,000 in cash at closing, plus another €1,400,000 in cash and €5,600,000 in shares annually upon meeting profit targets in each of 2021, 2022 and 2023. All of the cash in Ideenion will be paid out to the Vendors prior to closing with the exception of €1,500,000. We again note, the potential share issuance is based on Ideenion reaching profit milestones over a three year period with shares being issued at the higher of HK$0.52 or the three-month daily average.
H2:20 Results. AMFG reported second half 2020 results (ending September 30) with Revenue of HK$100.8 million, down significantly due to the impact of COVID. No Apollo IE hypercars were delivered in the period, although one was delivered prior to the end of the calendar year. Auto engineering services Revenue was just HK$2.6 million as many projects were put on hold. All of the legacy businesses were hit hard by COVID, as well as Property Investment due to Shenyang expropriating property that the Company owned, which resulted in Other Gains, Net of HK$255.9 million and HK$281.2 million of Land Appreciation Tax in the period; AMFG turned a profit on the building as it had previously been marked up. Net Loss for the period was HK$141.8 million, or HK$1.98 cents per share.
Model Update. The model continues to be subject to significant fluctuations due to COVID, however it will get a bit of stability with the closing of the Ideenion acquisition and the world creeping back to normalcy with global vaccine distribution underway. One Apollo IE was delivered before the end of calendar Q4, marking the third such delivery; two were delivered prior to the completion of the acquisition. We expect a total of four to six IE’s to be delivered over the course of fiscal 2021, with the remainder falling in fiscal 2022. The launch of the next Apollo model has been pushed back, and will now be launched later this year. The DeTomaso P72 has been delayed as well, with deliveries now expected in 2022, however AMFG should begin receiving its license fee on each car produced starting later this year. We continue to expect the auto products and services business to grow quickly as the world exits COVID and ramp significantly starting in 2022 as a number of the previously discussed products roll out to market. As a result of these changes, our estimated Revenue and Net Profit numbers for fiscal 2021 and 2022 have contracted.
Retirement of Non-Executive Director. On December 30, Co-Chairman Zhang Jinbing notified the Board he would not seek re-election to the Board due to his other business commitments. Mr. Zhang was previously Chairman prior to the change in direction of AMFG in late 2016.
Maintaining Rating & Target. Getting the Ideenion deal done is an important step for AMFG as it broadens the Company’s reach and tier one customer base. We continue to believe AMFG is ideally positioned for the changing auto industry with its engineering capabilities and product offerings. As such, we are reiterating our Buy rating and HK$1.50 target price on Apollo Future Mobility Group. Our target price is based on a P/E multiple of 25 times our fiscal 2022 Diluted EPS estimate of HK$5.64 cents.
Read Complete Report
Alternative Investments
All kinds of buys in the hospitality Industry especially restaurant and bar properties
If you want to learn more about how to take advantage of opportunities created by the Covid crisis
Message me on Linkedin
https://www.linkedin.com/in/carldilley/
Please subscribe to our newsletter to get ongoing Real Estate and Alternative Investing updates:
Black Swan Connection Newsletter Signup
| April 1, 2021 COMPANY QUOTES, LISTINGS RESEARCH AND NEWS Antibe Therapeutics, Inc (ATBPF) Profile 11/11/2018 News AzuerRx Biopharma, Inc. (AZRX) Profile 7/11/2019 News Can B Corp (CANB) Profile News Cavitation Technologies, Inc. (CVAT) Profile 8/22/2019 News Endurance Exploration Group, Ltd (EXPL) Profile 03-26/19 News Guangdong Land Holdings Limited (124) HK Profile 6/6/2019 News H-Source Holdings, Ltd (HSCHF) Profile 4/9/2019 News Summit Wireless Technologies, Inc. 06/04/19 Social Reality, Inc. (SRAX) Profile 02/05/19 News Apollo Future Mobility Ltd. (HK 0860) Profile 2/23/2020 News |
ValuEngine Weekly Report
By: Herb Blank
03/08/2021 What’s in Your Core?
If you are an investor with less than $1 billion to invest and a holding horizon of more than 3 months, do NOT buy SPY to access exposure to the S&P 500. This is true even though SPY has the most assets under management and the highest average trading volume by far. The simple fact is that there are more advantageous alternatives to gain access to US market exposure. Read on for the numbers and detailed discussion on better alternatives.
The overall strategy most institutions and financial advisors employ for equity allocation is called “core-satellite.” The core usually comprises at least 40% and often up to 60% or more of the overall equity exposure, which in turn is generally between 50% – 70% of the overall plan. Financial advisors will ratchet the individual’s equity exposure down as clients age, but generally it is the tactical satellite funds that get liquidated first. Then the core starts getting reduced. For most US investors following the core-satellite model, the core is a fund based upon a broadly diversified index or a fund that is benchmarked to such an index.
| Summary of VE Stock Universe Stocks Undervalued 35.13% Stocks Overvalued 64.87% Stocks Undervalued by 20% 13.75% Stocks Overvalued by 20% 38.52% |
To subscribe to our bulletins and receive content whenever it is published, subscribe at our blog HERE
Want to learn more about ValuEngine? Our methods? Our history?
Check out our video presentation HERE
SMM Research Partners
Black Swan Research Coverage and Subscription Service
Click Here>>
Event Calendar Updates
Not Surprisingly most conference events are cancelled or postponed-
LD Micro Main Event (XIII)
LD Micro was a great success.
You can listen to the recorded presentations here.
Rocky Mountain Microcap Conference
From Dave Lavigne-Trickle Research
A few weeks ago we completed Rocky Mountain Microcap Conference VI. Replays of all the presentations are now available on the conference site at the following URL/page if you would like to view them:
http://rockymtmicro.com/rmmc-conference-vi-presenters-2/
The page includes a table that will take you to each presenting company’s website, their Yahoo page, a replay of the virtual presentation and a copy of their conference powerpoint presentation. Also, for those presenting companies that are Trickle coverage companies, we have provided a link that will take you to that research at www.trickleresearch.com as well. Also, we will have research updates on most of these (as well as other coverage names) shortly.
Those companies include:
- OncoSec Medical Incorporated (ONCS)
- SRAX (SRAX)
- Summit Wireless Technologies, Inc. (WISA)
- Texas Mineral Resources Corp. (TMRC)
- Vext Science, Inc. (VEXT)
- Assure Holding Inc. (ARHH) (you will need a paid Trickle subscription to access this research)
- If You Can – If You Can is a private company, but the conference site includes a profile on the Company that we would encourage you to take a look at.
Dave Lavigne – Senior Analyst/Manager
Trickle Research LLC
720-394-1019
Visit our homepage for up to the minute Financial News, Quotes and our Latest Black Swan Connection Newsletter
-SMM Distribution Update-
Distribution (Reach)
SMM Global Twitter Acct (Impressions last 30 days) 520
SMM Global Facebook Page (Reach last-30 days) 6,462
SMM Linkedin Pages (contacts) 1,100
SMM Youtube Channel (followers) 6
SMM Instagram Page * (followers) 11
Direct Email * 249,000
Total 256,460